C-myc Biomarker Study for Diabetic Foot Ulcers

Exclusion Criteria

• •An individual who meets any of the following criteria will be excluded from participation in this study:
• •1. Patient participating in an interventional clinical trial within 1 month of Visit 1
• •2. Currently receiving radiation to target area or chemotherapy
• •3. Participants with Charcot's foot or other foot deformities that prevents adequate targeted ulcer offloading
• •4. Participant with active severe infection or osteomyelitis at the time of screening
• •5. History of cancer within last 3 years, other than non-melanoma skin cancer
• •6. Known or suspected malignancy of current study ulcer
• •7. Use of adjunctive therapy within previous 30 days
• •8. Currently receiving medication considered to be systemic glucocorticoids
• •9. Plan to perform a vascular intervention, such as surgical bypass, angioplasty or stenting, or \< 1 month from a prior ipsilateral vascular intervention
• •10. Any history of concomitant medical condition that, in the opinion of the investigator(s), would compromise the participant's ability to safely complete the study